T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Archer Aviation
ACHR
$5.37B
| $8.45M | ﹤0.01% |
1,123,689
-1,640,598
| -59% | -$15.4M |
|
1252
Safety Insurance
SAFT
$1.52B
| $8.38M | ﹤0.01% |
107,507
-55,755
| -34% | -$4.12M |
|
1253
American Airlines Group
AAL
$9.97B
| $8.37M | ﹤0.01% |
545,947
+36,065
| +7% | +$487K |
|
1254
Jefferies Financial Group
JEF
$12.9B
| $8.33M | ﹤0.01% |
134,377
+7,400
| +6% | +$424K |
|
1255
EverQuote
EVER
$867M
| $8.32M | ﹤0.01% |
308,126
+113,733
| +59% | +$2.76M |
|
1256
Donaldson
DCI
$11.2B
| $8.3M | ﹤0.01% |
93,633
+4,361
| +5% | +$379K |
|
|
BCYC
1257
Bicycle Therapeutics
BCYC
$284M
| $8.3M | ﹤0.01% |
1,171,787
-213,007
| -15% | -$1.57M |
|
1258
Freshpet
FRPT
$3.48B
| $8.26M | ﹤0.01% |
135,529
+16,589
| +14% | +$941K |
|
1259
BorgWarner
BWA
$14B
| $8.16M | ﹤0.01% |
181,148
+5,610
| +3% | +$246K |
|
1260
Blue Owl Capital
OWL
$19.1B
| $8.16M | ﹤0.01% |
546,160
-1,337,994
| -71% | -$20.9M |
|
|
TAXE
1261
Intermediate Municipal Income ETF
TAXE
$197M
| – | – |
0
| – | – |
|
1262
Brown-Forman Class B
BF.B
$12.8B
| $8.11M | ﹤0.01% |
311,169
-6,541
| -2% | -$184K |
|
|
FLG
1263
Flagstar Bank National Association
FLG
$5.9B
| $8.07M | ﹤0.01% |
641,058
-530
| -0.1% | -$6.34K |
|
1264
Fortune Brands Innovations
FBIN
$5.83B
| $8.06M | ﹤0.01% |
161,023
+10,395
| +7% | +$522K |
|
1265
Antero Resources
AR
$11.5B
| $8.01M | ﹤0.01% |
232,279
+14,876
| +7% | +$504K |
|
1266
Trinity Capital Inc.
TRIN
$1.73B
| $7.99M | ﹤0.01% |
545,047
+365,193
| +203% | +$5.44M |
|
|
ZEPP
1267
Zepp Health
ZEPP
$79.9M
| $7.97M | ﹤0.01% |
295,967
+44,619
| +18% | +$1.59M |
|
1268
Regal Rexnord
RRX
$11.5B
| $7.95M | ﹤0.01% |
56,615
+2,856
| +5% | +$406K |
|
1269
American Superconductor
AMSC
$1.56B
| $7.91M | ﹤0.01% |
274,844
-121,488
| -31% | -$5.25M |
|
1270
Landstar System
LSTR
$6.4B
| $7.89M | ﹤0.01% |
54,925
+2,302
| +4% | +$307K |
|
|
CFLT
1271
DELISTED
Confluent
CFLT
| $7.87M | ﹤0.01% |
260,326
-115,384
| -31% | -$2.83M |
|
1272
UFP Industries
UFPI
$5.06B
| $7.86M | ﹤0.01% |
86,345
-312
| -0.4% | -$28.6K |
|
1273
Immatics
IMTX
$1.33B
| $7.86M | ﹤0.01% |
748,035
+23,228
| +3% | +$234K |
|
1274
Phinia Inc
PHIN
$2.71B
| $7.84M | ﹤0.01% |
125,023
+8,851
| +8% | +$489K |
|
1275
American Financial Group
AFG
$12B
| $7.83M | ﹤0.01% |
57,260
+2,449
| +4% | +$336K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.